NCT00002142View on ClinicalTrials.gov

An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Cidofovir

DRUG

Probenecid

Trial Locations (1)

085406681

Besselaar Associates, Princeton

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY